Logo image
Back
Efficacy evaluations of the use of oral tilmicosin in pneumonic calves
Journal article   Peer reviewed

Efficacy evaluations of the use of oral tilmicosin in pneumonic calves

L Fodor, Lloyd Reeve-Johnson, A Hodge and J Varga
The Veterinary Journal, Vol.159(2), pp.194-200
2000
DOI: https://doi.org/10.1053/tvjl.1999.0443
url
https://doi.org/10.1053/tvjl.1999.0443View
Published Version

Abstract

calf pneumonia oral tilmicosin enrofloxacin
The therapeutic effect of oral tilmicosin was compared with enrofloxacin, and the efficacy of three doses of the drug was examined in two fully randomized blinded field trials. Pneumonic milk-fed calves between 3 days and 2.5 months of age were allocated into two groups in trial 1 (50 animals) and into three groups in trial 2 (69 calves). In the first trial, the animals were treated with 25 mg/kg/day tilmicosin or 2.5 mg/kg/day enrofloxacin in milk for 5 days. In the second trial, the calves received either 25 mg/kg/day tilmicosin for 5 days or 3 days, or else 12.5 mg/kg tilmicosin for 5 days. All calves were clinically examined for 10 days. In the first trial, oral, tilmicosin at a dose of 25 mg/kg/day for 5 days proved to be effective for the treatment of endemic pasteurellosis of milk-fed calves. The efficacy was the same as that of enrofloxacin. All three doses in the second trial were effective and were statistically equivalent to the original dose tested. (C) 2000 Harcourt Publishers Ltd.

Details

Metrics

284 Record Views
9 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web Of Science research areas
Veterinary Sciences

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image